Publications by authors named "Allegra Freelander"

Claim this Profile
S
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.
Cristina Guarducci, Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Heraud, Allegra Freelander

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective.
Fiona H Zhou, Teesha Downton, Allegra Freelander, Joshua Hurwitz, C Elizabeth Caldon

Front Cell Dev Biol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic.
Sanjeev Kumar, Allegra Freelander, Elgene Lim

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer.
Allegra Freelander, Lauren J Brown, Andrew Parker, Davendra Segara, Neil Portman

Genes (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis